Form D · Other Technology
Health Rosetta Group PBC
Seattle, WA · CIK 0001762585
Offering snapshot reported May 24, 2022 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 13, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2022 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Nov 17, 2020 | Amendment | $968,560 | $768,560vs Dec 31, 2018 | 10 | SEC filing |
| Dec 31, 2018 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-446842
Source: Form D, filed May 24, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Chase | Director, Executive |
| Sean Schantzen | Director, Executive |
| Melissa Taylor | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
3019 Ne 127 Th St. #27633
Seattle, WA, 98165
Seattle, WA, 98165